# Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10)

> **NCT01294241** · PHASE2 · COMPLETED · sponsor: **Birken AG** · enrollment: 10 (actual)

## Conditions studied

- Inherited Epidermolysis Bullosa

## Interventions

- **DRUG:** Oleogel-S10
- **DEVICE:** Mepilex® soft silicone faced polyurethane foam dressing

## Key facts

- **NCT ID:** NCT01294241
- **Lead sponsor:** Birken AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01294241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01294241, "Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01294241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*